Company
Korea (the Republic of)Samyang Biopharmaceuticals Corporation, Daedeok District, Korea (the Republic of) – FDA Inspections
Inspection records and compliance data for Samyang Biopharmaceuticals Corporation in Daedeok District. 1 FDA inspection on record, 1 Form 483, last inspected August 30, 2019.
Company Profile
This profile covers Samyang Biopharmaceuticals Corporation based in Daedeok District, Korea (the Republic of).
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected August 30, 2019.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 30, 2019 | Not classified | Human Drugs | 1102618 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 1 inspection · last April 8, 2019
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Samyang Biopharmaceuticals Corporation
FEI Number
3009291004
Address
79 Sinildong-ro, Daedeok District, Korea (the Republic of)
Country
Korea (the Republic of)
ID: 8a875cdc-fb6c-4e62-b6e1-523c0adf3cb5